Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A multi-faceted invention that has identified novel compositions that may be useful for pharmacological, diagnostic and research development for more effective pain control. An in vitro enzymatic process that produces novel glucuronyl derivatives of canna More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jun 2006 - 952 pages - $2,495
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Nov 2011 - 7 pages - $75
Sep 2007 - 18 pages - $1,695
Jan 2009 - 14 pages - $1,695
Dec 2009 - 10 pages - $1,695
May 2011 - 15 pages - $250
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Accident & Trauma (other)
- Back Pain
- Bone fractures
- Burns
- CNS trauma
- Drug overdose
- Hemorraghic trauma
- Muscle sprain/strain
- Poisioning
- Reperfusion injury (lung/heart)
- Stroke/traumatic brain injury
- Tissue grafting
- Wound closure/surgical adhesive
- Wound/ulcer healing
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us